Research and Markets: MediPoint: Renal Denervation - US Analysis and Market Forecasts

DUBLIN--()--Research and Markets ( has announced the addition of the "MediPoint: Renal Denervation - US Analysis and Market Forecasts" report to their offering.

Numerous medical device news sources and industry executives have proclaimed renal denervation to be the top medical device breakthrough of the past two years, and for good reason. Hypertension is one of the most prevalent chronic conditions worldwide, with some studies estimating that 50% of the adult population globally will have the disease in the next 20 years. With limited effectiveness from pharmacotherapy, medical device therapy has the potential for significant adoption in the treatment of resistive hypertension and uncontrolled hypertension, once efficacy and cost-effectiveness are proven.

Additionally, the degree of blood pressure reduction found in long-term clinical trials from such a well-tolerated procedure has generated notable optimism about the intervention's application in other conditions where hyperactivity of the sympathetic nervous system plays a significant role, such as congestive heart failure.

The renal denervation market in the United States will grow from essentially nothing in 2012 as the intervention was not approved for any indication in the United States in 2012. That is expected to change by the end of the forecast period in 2019. By then, the intervention is expected to be approved in both uncontrolled hypertension and resistant hypertension patients. The adoption of the procedure will be much higher in the US.


- An overview of hypertension, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.

- Annualized US renal denervation market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018.

- Investigation of current and future market competition for renal denervation

- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.

- Competitor assessment including device approval analysis and device sales forecasts.

- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.

- Analysis of unmet needs within the market and opportunities for future players.

- Technology trends evaluation to assess strength of pipeline.

- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.

- Company profiles including business description, financial overview and SWOT analysis.

- Coverage of key market players.

- Strategic assessment of the renal denervation sector through market impact analysis, future market scenario and company analysis.

- Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists

Companies Mentioned

Ablative Solutions


Best Medical International

Boston Scientific Corporation



Cordis Corporation and Johnson & Johnson


Kona Medical


Mercator MedSystems

Northwind Medical

ReCor Medical

Sound Interventions

St. Jude Medical

Symple Surgical

Terumo Corporation

Verve Medical

and many more...

For more information visit

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular Devices



Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular Devices